76 related articles for article (PubMed ID: 17483304)
21. DNA damage and repair in gastric cancer--a correlation with the hOGG1 and RAD51 genes polymorphisms.
Poplawski T; Arabski M; Kozirowska D; Blasinska-Morawiec M; Morawiec Z; Morawiec-Bajda A; Klupińska G; Jeziorski A; Chojnacki J; Blasiak J
Mutat Res; 2006 Oct; 601(1-2):83-91. PubMed ID: 16843501
[TBL] [Abstract][Full Text] [Related]
22. Association of p53 and MSH2 with recombinative repair complexes during S phase.
Zink D; Mayr C; Janz C; Wiesmüller L
Oncogene; 2002 Jul; 21(31):4788-800. PubMed ID: 12101417
[TBL] [Abstract][Full Text] [Related]
23. The RAD51 gene family, genetic instability and cancer.
Thacker J
Cancer Lett; 2005 Mar; 219(2):125-35. PubMed ID: 15723711
[TBL] [Abstract][Full Text] [Related]
24. Mechanisms of pathogenicity in human MSH2 missense mutants.
Ollila S; Dermadi Bebek D; Jiricny J; Nyström M
Hum Mutat; 2008 Nov; 29(11):1355-63. PubMed ID: 18951462
[TBL] [Abstract][Full Text] [Related]
25. DNA repair after irradiation in glioma cells and normal human astrocytes.
Short SC; Martindale C; Bourne S; Brand G; Woodcock M; Johnston P
Neuro Oncol; 2007 Oct; 9(4):404-11. PubMed ID: 17704360
[TBL] [Abstract][Full Text] [Related]
26. Msh2 deficiency increases susceptibility to benzo[a]pyrene-induced lymphomagenesis.
Zienolddiny S; Ryberg D; Svendsrud DH; Eilertsen E; Skaug V; Hewer A; Phillips DH; te Riele H; Haugen A
Int J Cancer; 2006 Jun; 118(11):2899-902. PubMed ID: 16381012
[TBL] [Abstract][Full Text] [Related]
27. DNA mismatch repair protein MSH2 dictates cellular survival in response to low dose radiation in endometrial carcinoma cells.
Martin LM; Marples B; Davies AM; Atzberger A; Edwards C; Lynch TH; Hollywood D; Marignol L
Cancer Lett; 2013 Jul; 335(1):19-25. PubMed ID: 23376256
[TBL] [Abstract][Full Text] [Related]
28. The effects of MSH2 deficiency on spontaneous and radiation-induced mutation rates in the mouse germline.
Burr KL; van Duyn-Goedhart A; Hickenbotham P; Monger K; van Buul PP; Dubrova YE
Mutat Res; 2007 Apr; 617(1-2):147-51. PubMed ID: 17331550
[TBL] [Abstract][Full Text] [Related]
29. Loss of Msh2 and a single-radiation hit induce common, genome-wide, and persistent epigenetic changes in the intestine.
Herberg M; Siebert S; Quaas M; Thalheim T; Rother K; Hussong M; Altmüller J; Kerner C; Galle J; Schweiger MR; Aust G
Clin Epigenetics; 2019 Apr; 11(1):65. PubMed ID: 31029155
[TBL] [Abstract][Full Text] [Related]
30. Multiple synchronous primary gynecologic malignancies in an MSH2 mutation carrier with endometriosis.
Shoni M; Parra-Herran CE; May T; Wright AA; Feltmate CM
J Clin Oncol; 2013 Jan; 31(3):e33-6. PubMed ID: 23213089
[No Abstract] [Full Text] [Related]
31. Fibroblast growth factor receptor 4 induced resistance to radiation therapy in colorectal cancer.
Ahmed MA; Selzer E; Dörr W; Jomrich G; Harpain F; Silberhumer GR; Müllauer L; Holzmann K; Grasl-Kraupp B; Grusch M; Berger W; Marian B
Oncotarget; 2016 Oct; 7(43):69976-69990. PubMed ID: 27650548
[TBL] [Abstract][Full Text] [Related]
32. Quantifying Microsatellite Mutation Rates from Intestinal Stem Cell Dynamics in Msh2-Deficient Murine Epithelium.
Christopher J; Thorsen AS; Abujudeh S; Lourenço FC; Kemp R; Potter PK; Morrissey E; Hazelwood L; Winton DJ
Genetics; 2019 Jul; 212(3):655-665. PubMed ID: 31126976
[TBL] [Abstract][Full Text] [Related]
33. Survival outcomes in locally advanced dMMR rectal cancer: surgery plus adjunctive treatment vs. surgery alone.
Ni K; Zhan Y; Liu Z; Yuan Z; Wang S; Zhao XZ; Ping H; Liu Y; Wang W; Yan S; Xin R; Han Q; Zhang Q; Li G; Zhang X; Wang G; Zhang Z; Ma H; Zhang C
BMC Cancer; 2023 Oct; 23(1):1013. PubMed ID: 37864137
[TBL] [Abstract][Full Text] [Related]
34. Delivery of Personalized Care for Locally Advanced Rectal Cancer: Incorporating Pathological, Molecular Genetic, and Immunological Biomarkers Into the Multimodal Paradigm.
Ryan ÉJ; Creavin B; Sheahan K
Front Oncol; 2020; 10():1369. PubMed ID: 32923389
[TBL] [Abstract][Full Text] [Related]
35. Genetics of rectal cancer and novel therapies: primer for radiologists.
Mondaca S; Yaeger R
Abdom Radiol (NY); 2019 Nov; 44(11):3743-3750. PubMed ID: 31073721
[TBL] [Abstract][Full Text] [Related]
36. Diversity of the clinical presentation of the MMR gene biallelic mutations.
Bougeard G; Olivier-Faivre L; Baert-Desurmont S; Tinat J; Martin C; Bouvignies E; Vasseur S; Huet F; Couillault G; Vabres P; Le Pessot F; Chapusot C; Malka D; Bressac-de Paillerets B; Tosi M; Frebourg T
Fam Cancer; 2014 Mar; 13(1):131-5. PubMed ID: 24068316
[TBL] [Abstract][Full Text] [Related]
37. Effects of radiation on levels of DNA damage in normal non-adjacent mucosa from colorectal cancer cases.
Sheridan J; Tosetto M; Gorman J; O'Donoghue D; Sheahan K; Hyland J; Mulcahy H; Gibbons D; O'Sullivan J
J Gastrointest Cancer; 2013 Mar; 44(1):41-5. PubMed ID: 23065707
[TBL] [Abstract][Full Text] [Related]
38. Microsatellite instability and survival in rectal cancer.
Samowitz WS; Curtin K; Wolff RK; Tripp SR; Caan BJ; Slattery ML
Cancer Causes Control; 2009 Nov; 20(9):1763-8. PubMed ID: 19669908
[TBL] [Abstract][Full Text] [Related]
39. Cerebral primitive neuroectodermal tumor in an adult with a heterozygous MSH2 mutation.
Jeans AF; Frayling I; Jasani B; Side L; Blesing C; Ansorge O
Nat Rev Clin Oncol; 2009 May; 6(5):295-9. PubMed ID: 19390556
[TBL] [Abstract][Full Text] [Related]
40. Biallelic mutation of MSH2 in primary human cells is associated with sensitivity to irradiation and altered RAD51 foci kinetics.
Barwell J; Pangon L; Hodgson S; Georgiou A; Kesterton I; Slade T; Taylor M; Payne SJ; Brinkman H; Smythe J; Sebire NJ; Solomon E; Docherty Z; Camplejohn R; Homfray T; Morris JR
J Med Genet; 2007 Aug; 44(8):516-20. PubMed ID: 17483304
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
